Chapter 5.10
The Cochrane Hepatobiliary Group
Christian Gluud,
Christian Gluud
Search for more papers by this authorChristian Gluud,
Christian Gluud
Search for more papers by this authorBook Editor(s):Juan Rodés MD,
Jean-Pierre Benhamou MD,
Andres T. Blei MD,
Jürg Reichen MD,
Mario Rizzetto MD,
Juan Rodés MD
Director General, Hospital Clinic; Professor of Medicine, University of Barcelona, Barcelona, Spain
Search for more papers by this authorJean-Pierre Benhamou MD
Professor of Hepatology, Université Denis Diderot Paris 7, Assistance Publique — Hôpitaux de Paris and Inserm U773, Service d'Hépatologie, Hôpital Beaujon, Clichy, France
Search for more papers by this authorAndres T. Blei MD
Professor of Medicine and Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
Search for more papers by this authorJürg Reichen MD
Professor of Medicine, University of Bern; Chief of Hepatology, University Hospital, Bern, Switzerland
Search for more papers by this authorMario Rizzetto MD
Professor of Gastroenterology, University of Turin, Turin, Italy
Search for more papers by this authorFirst published: 18 June 2007
References
- Chalmers I (2001) Comparing like with like: some historical milestones in the evolution of methods to create unbiased comparison groups in therapeutic experiments. Int J Epidemiol 30, 1156–1164.
- Chalmers TC, Eckhardt RD, Reynolds WE et al. (1955) The treatment of acute infectious hepatitis. Controlled studies of the effects of diet, rest, and physical reconditioning on the acute course of the disease and on the incidence of relapses and residual abnormalities. J Clin Invest 34, 1163–1235.
- Chalmers TC (1976) Randomized controlled clinical trials in diseases of the liver. Prog Liver Dis 5, 450–456.
- Sackett DL, Straus SE, Richardson WS et al. (2000) Evidence-Based Medicine; How to Practise and Teach EBM, 2nd edn. Edinburgh: Churchill Livingstone.
- R Hayward (ed.) (2002) Users' Guides Interactive. Chicago: JAMA Publishing Group. URL http://wwwusersguides.org.
- Gluud C, Gluud LL (2005) Evidence based diagnostics. Br Med J 330, 724–726.
- Kjaergard LL, Nikolova D, Gluud C (1999) Randomized trials in hepa-tology: predictors of quality. Hepatology 30, 1134–1138.
- Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273, 408–412.
- Moher D, Pham B, Jones A et al. (1998) Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyses' Lancet 352, 609–613.
- Kjaergard LL, Villumsen J, Gluud C (2001) Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 135, 982–989.
- Balk EM, Boris PA, Moskowitz H et al. (2002) Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA 287, 2973–2982.
- Als-Nielsen B, Chen W, Gluud LL et al. (2004) Are trial size and quality associated with treatment effects in randomized trials' Observational study of 523 randomized trials [abstract]. 12th International Cochrane Colloquium. Ottawa: The Cochrane Collaboration, pp. 102–103. http://www.cochrane.org/colloquia/abstracts/ottawa/P-003.htm
-
Deeks JJ,
Dinnes J,
D'Amico R et al.
(2003)
Evaluating non-randomized intervention studies.
Health Technol Assess
7,
1–173.
10.3310/hta7270 Google Scholar
- Kjaergard LL, Liu J, Als-Nielsen B, Gluud C (2003) Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. JAMA 289, 217–222.
- Tatsioni A, Deborah AZ, Aronson N et al. (2005) Challenges in systematic reviews of diagnostic technologies. Ann Intern Med 142, 1048–1055.
- D'Amico G, Morabito A, Pagliaro L, Marubini E (1986) Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 31, 468–475.
- Christensen E (2004) Prognostic models including the Child-Pugh, MELD and Mayo risk scores — where are we and where should we go? J Hepatol 41, 344–350.
- Ioannidis JP, Evans SJ, Gotzsche PC et al. (2004) Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 141, 781–788.
- Chou R, Helfand M (2005) Challenges in systematic reviews that assess treatment harms. Ann Intern Med 142, 1090–1099.
- Pocock SJ (1996) Clinical Trials – A Practical Approach. Chichester: John Wiley & Sons.
- Als-Nielsen B, Gluud LL, Gluud C (2004) Methodological quality and treatment effects in randomized trials — a review of six empirical studies [abstract]. 12th International Cochrane Colloquium. Ottawa: The Cochrane Collaboration, pp. 88–89. http://www.cochrane.org/colloquia/abstracts/ottawa/O-072.htm
- Kjaergard LL, Als-Nielsen B (2002) Association between competing interests and authors' conclusions: epidemiological study of randomized trials published in the BMJ. Br Med J 325, 249–252.
- Als-Nielsen B, Chen W, Gluud C, Kjaergard LL (2003) Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events' JAMA 290, 921–928.
- Bekelman JE, Li Y, Gross CP (2003) Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289, 454–465.
- Lexchin J, Bero LA, Djulbegovic B, Clark O (2003) Pharmaceutical industry sponsorship and research outcome and quality: systematic review. Br Med J 326, 1167–1170.
- House of Commons Health Committee (2005) The Influence of the Pharmaceutical Industry. Fourth Report of Session 2004–05, Vol. I. URL http://www.publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/4202.htm.
- Friedman HP, Goldberg JD (1996) Meta-analysis: An introduction and point of view. Hepatology 23, 917–928.
- Egger M, Jüni P, Bartlett C et al. (2003) How important are comprehensive literature searches and the assessment of trial quality in systematic reviews' Empirical study. Health Technol Assess 7, 1–76.
- JPT Higgins, S Green (eds) (2005) Cochrane Handbook for Systematic Reviews of Interventions 4.2. [updated March 2005]. In: The Cochrane Library, Issue 2, 2005. Chichester: John Wiley & Sons.
- Santaguida PL, Helfand M, Raina P (2005) Challenges in systematic reviews that evaluate drug efficacy or effectiveness. Ann Intern Med 142, 1066–1072.
- Simes RJ (1986) The case for an international registry of clinical trials. J Clin Oncol 4, 1529–1541.
- Dickersin K (1988) Report from the panel on the case for registers of clinical trials at the Eighth Annual Meeting of the Society for Clinical Trials. Control Clin Trials 9, 76–81.
- Gluud C (1998) ‘Negative trials’ are positive! J Hepatol 28, 731–733.
- Dickersin K, Rennie D (2003) Registering clinical trials. JAMA 290, 516–523.
- Krleza-Jeric K, Chan A-W, Dickersin K et al. (2005) Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1). Br Med J 330, 956–958.
- Chan A-W, Hrobjartsson A, Haahr MT et al. (2004) Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 291, 2457–2465.
- Chan A-W, Krleza-Jeric K, Schmid I, Altman DG (2004) Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ 171, 735–740.
- Gluud C (1999) Evidence based medicine in liver. Liver 19, 1–2.
- Gluud C, Nikolova D (1998) Quality assessment of reports on clinical trials in the Journal of Hepatology. J Hepatol 29, 321–327.
- Kjaergard LL, Frederiksen SL, Gluud C (2002) Validity of randomized trials in Gastroenterology from 1964–2000. Gastroenterology 122, 1157–1160.
- Kjaergard LL, Gluud C (2002) Funding, disease area, and internal validity of hepatobiliary randomized trials. Am J Gastroenterol 97, 2708–2713.
- Pagliaro L, D'Amico G, Pasta L et al. (1996) Efficacy and efficiency of treatments in portal hypertension. In: R De Franchis (ed.) Portal Hypertension II. Proceedings of the Second Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Oxford: Blackwell Science, pp. 159–179.
- Antman EM, Lau J, Kupelnick B et al. (1991) A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA 268, 240–248.
- Chan A-W, Altman DG (2005) Epidemiology and reporting of randomized trials published in Pub Med journals. Lancet 365, 1159–1162.
- Gluud C (1999) Trials and errors in clinical research. Lancet 354, SIV59.
- J Wang, C Gluud (eds) (2002) Evidence-Based Medicine and Clinical Practice. Beijing: Science Publisher.[in Chinese].
- Hill CL, LaValley MP, Felson DT (2002) Discrepancy between published report and actual conduct of randomized trials. J Clin Epidemiol 55, 783–786.
- Devereaux PJ, Choi PT, El-Dika S et al. (2004) An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. J Clin Epidemiol 57, 1232–1236.
- Soares HP, Daniels S, Kumar A et al. (2004) Bad reporting does not mean bad methods for randomized trials: observational study of randomized controlled trials performed by the Radiation Therapy Oncology Group. Br Med J 328, 22–24.
- Liberati A, Himel HN, Chalmers TC (1986) A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol 4, 942–951.
- Pildal J, Chan A-W, Hróbjartsson A et al. (2005) Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study. Br Med J 330, 1049.
- A Maynard, I Chalmers (eds) (1997) Non-random Reflections on Health Services Research. On the 25th Anniversary of Archie Cochrane's Effectiveness and Efficiency. London: BMJ Publishing Group.
- Olsen O, Middleton P, Ezzo J et al. (2001) Quality of Cochrane reviews: assessment of sample from 1998. Br Med J 323, 829–832.
- Moja LP, Telaro E, D'Amico R et al. (2005) Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study. Br Med J 330, 1053.
- Gluud C, on behalf of the Cochrane Hepatobiliary Editorial Team (1999) The Cochrane Hepatobiliary Group. In: J Bircher, JP Benhamou, N McIntyre et al. (eds) Oxford Textbook of Clinical Hepatology, 2nd edn. Oxford: Oxford University Press, pp. 2145–2148.
- Gluud C, Als-Nielsen B, D'Amico G et al. (2005) The Cochrane Hepatobiliary Group. About The Cochrane Collaboration (Collaborative Review Groups (CRGs)). The Cochrane Library, Issue 2. Chichester: John Wiley & Sons.
- Wetterslev J, Thorlund K, Brok J, Gluud C (2005) Trial sequential analyses of six Cochrane Neonatal Review Group meta-analyses using actual information size (I). Abstract 24. Clinical Trials 2 (Suppl. 1), 32–33.
- Brok J, Thorlund K, Gluud C, Wetterslev J (2005) Trial sequential analyses of six Cochrane Neonatal Review Group meta-analyses considering adequacy of allocation concealment (II). Abstract P35. Clinical Trials 2 (Suppl. 1), 61–62.
- Thorlund K, Wetterslev J, Brok J, Gluud C (2005) Trial sequential analyses of six Cochrane Neonatal Review Group meta-analyses considering heterogeneity and trial weight (III). Abstract P36. Clinical Trials 2 (Suppl. 1), 62.
- Gluud C, Afroudakis AP, Caballeria J et al. (1993) Diagnosis and treatment of alcoholic liver disease in Europe. First report. Gastroenterol Int 6, 221–230.
- Kürstein P, Gluud LL, Kjellberg J et al. (2005) Agreement between reported use of interventions for liver diseases and research evidence in Cochrane systematic reviews. J Hepatol 43, 984–989.
